PriceList for 5(4)-Amino-4(5)-imidazolecarboxamide Hydrochloride - 2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC) – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

, , ,
PriceList for 5(4)-Amino-4(5)-imidazolecarboxamide Hydrochloride - 2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC) – Ruifu Detail:

Manufacturer Supply, High Purity, Commercial Production
Chemical Name: 2-Chloro-5-Iodobenzoic Acid
CAS: 19094-56-5

Chemical Name 2-Chloro-5-Iodobenzoic Acid
CAS Number 19094-56-5
CAT Number RF-PI438
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C7H4ClIO2
Molecular Weight 282.46
Solubility Soluble in Methanol
Brand Ruifu Chemical
Item Specifications
Appearance White or Pale Yellow Crystals
Assay / Analysis Method ≥99.0% (HPLC)
Melting Point 161.0~163.0℃
Loss on Drying ≤0.50%
Residue on Ignition ≤0.20%
Total Impurities ≤1.0%
Heavy Metals ≤20ppm
Residual Solvent Ethanol
Test Standard Enterprise Standard
Usage Intermediate of Empagliflozin (CAS: 864070-44-0)  

2-Chloro-5-Iodobenzoic Acid (CAS 19094-56-5) Synthetic Route

cas route 19094-56-5

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

1

2-Chloro-5-Iodobenzoic Acid (CAS: 19094-56-5) can be used as a pharmaceutical intermediate in the synthesis of Empagliflozin (CAS: 864070-44-0). Empagliflozin (trade name Jardiance) is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and causes sugar in the blood to be excreted by the kidneys and eliminated in urine. On August 1, 2014, the Food and Drug Administration (FDA) officially approved the drug for the treatment of type 2 diabetes, to improve and control blood glucose of adults. Empagliflozin is the third SGLT-2 inhibiting drugs approved by FDA. Another two SGLT-2 inhibitor drugs, Canagliflozin and Dapagliflozin, belonging to Johnson Pharmaceuticals, AstraZeneca and Bristol-Myers Squibb respectively, are approved by FDA in November 2013 and January 2014 respectively.


Product detail pictures:

PriceList for 5(4)-Amino-4(5)-imidazolecarboxamide Hydrochloride - 2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC) – Ruifu detail pictures


Related Product Guide:

PriceList for 5(4)-Amino-4(5)-imidazolecarboxamide Hydrochloride - 2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC) – Ruifu , The product will supply to all over the world, such as: , , ,

  • 5 Stars By from -

    5 Stars By from -
    Write your message here and send it to us